Stonvex
Discover
  • Dashboard
  • World News
  • Stock News
  • Rankings
  • Quant Picks
  • Screener
Markets
  • Heatmap
  • Gainers & Losers
Tools
  • Compare
  • Calendar
  • Community
HomeRankingsScreenerPortfolioCommunity
Stonvex
Log inGet Started
← Back

NVO

Side-by-side peer comparison using our theme tags and AI Score.

  • Overview
  • Financials
  • Filings
  • Short Interest
  • Ownership
  • Ratings
  • Peers
  • Options
  • News

Peer set

Same theme as NVO: biotech, healthcare. Ranked by Stonvex AI Score.

  • You
    NVO
    Novo Nordisk
    —
    —
    50
  • 1
    MRNA
    Moderna
    $42.80
    +5.29%
    82
  • 2
    LLY
    Eli Lilly
    $810.50
    +2.30%
    77
  • 3
    UNH
    UnitedHealth
    $485.20
    -2.51%
    53
  • 4
    BNTX
    BioNTech
    —
    —
    50
  • 5
    REGN
    Regeneron
    —
    —
    50
  • 6
    VRTX
    Vertex Pharma
    —
    —
    50
  • 7
    GILD
    Gilead Sciences
    —
    —
    50
  • 8
    AMGN
    Amgen
    —
    —
    50
  • 9
    JNJ
    Johnson & Johnson
    —
    —
    50
  • 10
    TMO
    Thermo Fisher
    —
    —
    50
  • 11
    WELL
    Welltower
    —
    —
    50
  • 12
    AMGN
    Amgen
    —
    —
    50
  • 13
    ABBV
    AbbVie
    —
    —
    50
  • 14
    BMY
    Bristol-Myers Squibb
    —
    —
    50
  • 15
    MDT
    Medtronic
    —
    —
    50
  • 16
    SYK
    Stryker
    —
    —
    50
  • 17
    ISRG
    Intuitive Surgical
    —
    —
    50
  • 18
    ZTS
    Zoetis
    —
    —
    50
  • 19
    DXCM
    DexCom
    —
    —
    50
  • 20
    XLV
    Health Care Select SPDR
    —
    —
    50
Stonvex

AI-powered stock research for US equities.

hello@stonvex.com

Product

  • Rankings
  • Quant Picks
  • Screener
  • Markets
  • Compare
  • Calendar

Company

  • About Stonvex
  • Pricing & Plans
  • Community
  • Help & FAQ
  • Contact Us
  • Legal

    • Terms of Service
    • Privacy Policy
    • Privacy Consent
    • Disclaimer
    • Notices & Updates

    © 2026 Stonvex. All rights reserved.

    This site is for informational purposes only. Not investment advice. Past performance does not guarantee future results. Stonvex is not a registered investment advisor (RIA). You must be 18 years or older to use this service.